Afamelanotide is a synthetic version of the naturally occurring hormone alpha-melanocyte stimulating hormone (α-MSH). It is a medication used to treat photodamage and skin disorders such as vitiligo, cutaneous lupus erythematosus, and solar urticaria. It works by stimulating the production of melanin, the pigment responsible for skin color, protecting the skin from further damage caused by ultraviolet (UV) light exposure. Afamelanotide is administered by subcutaneous injection. Common side effects include injection site reactions, nausea, and headache.
Afamelanotide is a prescription medication used to increase tolerance to sunlight in adults diagnosed with a specific condition called erythropoietic protoporphyria (EPP).
Here's a breakdown of Afamelanotide:
Purpose:
- Helps individuals with EPP spend more time in the sun without experiencing painful reactions.
- EPP is a rare genetic disorder causing severe sensitivity to sunlight and artificial light, leading to symptoms like burning, redness, and swelling of the skin.
How it works:
- Afamelanotide acts by stimulating the production of eumelanin, a pigment in the skin that helps block the harmful effects of sunlight.
- By increasing eumelanin levels, Afamelanotide improves the skin's ability to tolerate light exposure.
Dosage and administration:
- Afamelanotide is administered as a small implant inserted under the skin by a healthcare professional.
- The implant is typically placed every two months, before periods of high sun exposure.
It's important to note:
- Afamelanotide is not a cure for EPP and does not completely eliminate light sensitivity.
- It can cause side effects such as pain, redness, and swelling at the injection site, skin darkening, and nausea.
- Afamelanotide is not recommended for pregnant or breastfeeding women and should not be used by individuals under 18 years old.
Always consult a doctor before taking any medication, including Afamelanotide, to discuss if it's suitable for your individual needs and health condition.